Clinical Trial Update: Study to Asses Efficacy of Intralymphatic Immunotherapy [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for intralymphatic immunotherapy in allergy, noting completion of Phase 2 and Phase 3 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergy

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Allergy | Phase 2, Phase 3 | Status: COMPLETED